LINNEA SA

With a 40-year legacy, Linnea remains at the forefront of pharmaceutical manufacturing of premium active ingredients of botanical origin. Since its founding in 1982, the company has set itself apart through its expertise, dedication to quality, and continuous innovation in the field. Operating from a GMP-certified facility in Switzerland and with a strong emphasis on GACP compliance, the company guarantees that every ingredient meets rigorous quality standards, reflecting its pursuit of distinction. Through stringent controls and standardization, our fully validated manufacturing process ensures batch-to-batch consistency at all times, guaranteeing reliable quality and performance. Butylscopolamine: Peripherally-acting anticholinergic agent known for its antispasmodic properties. We have been producing our Butylscopolamine since 1985, sourcing it from the leaves of the Duboisia plant. As from 2022, this raw material is processed at our own facility in Australia. General grade butylscopolamine is suitable for diverse pharmaceutical forms. Hyject butylscopolamine is suitable for injectable pharmaceutical forms. CEP & DMF available - Ph.Eur. compliant - GACP compliant - manufactured under GMP standards. Vincamine & Vinpocetine Extracted from the seeds of Voacanga Africana, known for their high concentration of alkaloids. Seeds are sourced from the wild and carefully harvested to ensure minimal environmental impact. Vinpocetine is a symi-synthetic powder suitable for oral and injectable forms (Vinject) while Vincamine is a semi-synthetic powder suitable for oral forms. Common pharmaceutical uses include CNS conditions, such as: cerebrovascular disorder and cognitive impairement associated with cerebral vascular disease, cerebral circulation modulation and dizziness, vertigo, Ménière disease. Common dietary uses include concentration and memory support, concentration, neuroprotection and brain ageing. CEP and DMF available - Ph.Eur. compliant - GACP compliant - Manufactured under GMP standards Red Clover Extract IFL 40 Red clover has long been valued in herbal traditions for its rich content of isoflavones. Linnea's red clover ingredient can rely on a standardized fixed ratio of four main isoflavones - Formononetin, Biochanin A, Genistein and Daidzein. This feature ensures consistency and reliability across all batches. Total isoflavone agylcones range from 36% to 44%. The biological activity of Linnea's distinct ingredient is supported by several clinical data. Our product relies on a unique and proprietary extraction method, on IP-protected seeds and on flowers grown in European open fields. Common pharmaceutical uses include menopause symptoms (hot flashes, heart and bone health) and can be considered a natural alternative to Hormone Replacement Therapy. Common dietary uses encompass several application in women's health. Common cosmetic uses include anti-ageing and hair loss. DMF available - USP compliant - GACP compliant – Manufactured under GMP standards. Cannabinoids From 2014 the company has expanded its focus to cannabinoid research and development, launching its first full-pharma grade cannabinoid ingredient in 2016. Looking ahead, Linnea will reinforce its operations with a new state-of-the-art manufacturing plant dedicated exclusively to medical cannabis derivatives. This makes the company one of the very few industry leaders devoted to the highest levels of quality, driving sustained growth and cutting-edge advancements in the cannabinoid space. DMF available – CEP for CBD isolate - Manufactured under GMP standards